These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2640484)

  • 21. Bis-azo dyes interference with effector activation of antibodies.
    Kaszuba J; Konieczny L; Piekarska B; Rotterman I; Rybarska J
    J Physiol Pharmacol; 1993 Sep; 44(3):233-42. PubMed ID: 8241525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ; Hermes FF; Willems RW; Capel PJ; Koene RA
    J Immunol; 1984 Sep; 133(3):1185-9. PubMed ID: 6235283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human high-affinity Fc IgG receptor (Fc gamma RI)-mediated phagocytosis and pinocytosis in COS cells.
    Socolovsky M; Hockaday AR; Allen JM
    Eur J Cell Biol; 1994 Jun; 64(1):29-44. PubMed ID: 7957310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.
    Heyman B; Nose M; Weigle WO
    J Immunol; 1985 Jun; 134(6):4018-23. PubMed ID: 3872908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen.
    Getahun A; Heyman B
    Scand J Immunol; 2009 Sep; 70(3):277-87. PubMed ID: 19703017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
    Smith RI; Coloma MJ; Morrison SL
    J Immunol; 1995 Mar; 154(5):2226-36. PubMed ID: 7868896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of precipitating and nonprecipitating antibodies in glomerular immune complex formation.
    Cosio FG; Bakaletz AP; Mahan JD
    Kidney Int; 1990 Jun; 37(6):1429-37. PubMed ID: 2194065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of azo dyes on the formation of immune complexes.
    Rybarska J; Konieczny L; Roterman I; Piekarska B
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):317-27. PubMed ID: 1810223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG precipitating and non-precipitating antibodies in rabbits repeatedly injected with soluble and particulate antigens.
    Margni RA; Perdigon G; Gentile T; Abatangelo C; Dokmetjian J
    Vet Immunol Immunopathol; 1986 Sep; 13(1-2):51-61. PubMed ID: 3094236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonprecipitating asymmetric antibodies.
    Margni RA; Binaghi RA
    Annu Rev Immunol; 1988; 6():535-54. PubMed ID: 3289577
    [No Abstract]   [Full Text] [Related]  

  • 40. The subclass heterogeneity of pig IgG.
    Franek F
    Vet Immunol Immunopathol; 1987 Dec; 17(1-4):79-89. PubMed ID: 3433672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.